Strategic Collaborations: Setting Up for Success
Jun 
30
 | 
10:30am
Ticket Sales Are Closed
Text goes here
X

Nilesh Kumar

Partner, Novo Ventures

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

9:30am–10:00am

Registration Opens, Networking & Introductions

Ticket Sales Are Closed
Text goes here
X
July 
7
, 
2020
  | 
17:00
–
18:15 
CEST
Date TBD

July 7, 2020

17:00-18:15 CEST | 11:00-12:15 EDT | 08:00-09:15 PDT

[ONLINE VIA WEBINAR]

Strategic Collaborations: Setting Up for Success
Date TBD

17:00-18:15 CEST | 11:00-12:15 EDT | 08:00-09:15 PDT

Programme Overview

Entering a strategic collaboration as a startup can be enormously beneficial to get your innovation to the next level, whether it is around product development, distribution, testing and validation.But the size of the partner and your preparation can make or break your growth strategy.

 

Join JLABS, Allen & Overy and O’Melveny to learn more and discuss key questions such as:

 

  • Why collaborate?
  • What are the key considerations when starting a collaboration?
  • What are the basics of joint ventures?
  • What are the IP considerations?
  • How do you prepare for potential outcomes and exists?
  • What is the impact of insolvency or bankruptcy of one of the parties on the licensing agreement?

 

We will also look at issues such as force majeure, and provide some 'real life examples' seen during the COVID-19 crisis.

 

This program is part of the Johnson & Johnson Innovation – JLABS Legal Webinar Series for life science entrepreneurs, together with Allen & Overy and O’Melveny. You can register for other webinars in the series by visiting this page.

Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due June 11th, 2018.

Agenda

9:30am–10:00am

17:00 Introduction by JLABS

10:30am–11:00am

17:05 Joint presentation from Allen & Overy and O’Melveny

11:00am–11:30am

17:50 Q&A

9:30am–10:00am

18:15 Close

Speakers

Chioma Benjamin

Counsel, Allen & Overy

Chioma advises on a broad range of technology and commercial matters, including IT outsourcing projects, complex commercial arrangements and specialised telecoms sector contracts. Chioma also has extensive experience advising clients on strategic and transformational IT projects, including advice on related intellectual property licensing and collaboration arrangements, and data protection issues. She also advises on technology project renegotiations and dispute management.

Tine Carmeliet

Associate, Allen & Overy

Tine focuses on IP law, EU life sciences regulatory law and privacy and EU data protection law. She advises and assists clients both in non-litigious and litigious matters in these areas.

Recent highlights of her practice include multi-jurisdictional advice on European plant and seed legislation and genetically modified organisms, clinical trials, complex cross-border data protection matters and medical devices.

Geoff Kuziemko

Partner, O’Melveny

Geoff focuses his practice on assisting clients, primarily in the life sciences sector, with intellectual property and technology-intense transactions. His work runs the gamut of complex transactions, from out-bound license and in-bound license, development, commercialization, strategic alliance and joint venture, collaboration, and profit sharing agreements to commercial agreements for distribution, manufacture, and supply, as well as intellectual property due diligence for strategic acquisitions and financings involving life sciences businesses, products, and patents.

Cosmin Popa

Innovation Activation Manager, Johnson & Johnson Innovation – JLABS

Cosmin leads engagement activations for Johnson & Johnson Innovation, JLABS in Belgium and supports the broader EMEA region’s marketing, events and communications. Cosmin manages coordination of high-quality, diverse and distinctive programming ranging from one-on-one investor meetings, workshops to large panel series, networking, community and social events that serve JLABS and the broader EMEA entrepreneurial ecosystem.

Will Samengo-Turner

Partner, Allen & Overy

Will is one of the global relationship partners for Johnson & Johnson. Will’s practice focuses on corporate and commercial matters with a particular emphasis on the tech sector and its related industries both in Europe and in the United States. From emerging enterprises and startups to large public corporations, Will advises some of the world’s leaders in technology on a range of issues including M&A, JVs, and corporate finance (including venture and growth capital transactions).

Event Partners

Event Partners

About this Legal Webinar Series

Starting your own business and picking the right niche in no time

This program is part of the Johnson & Johnson Innovation –JLABS Legal Webinar Series for life science entrepreneurs, together with Allen & Overy and O’Melveny. You can register for other webinars in the series by visiting this page.

About this Legal Webinar Series

Starting your own business and picking the right niche in no time

Entering a strategic collaboration as a startup can be enormously beneficial to get your innovation to the next level, whether it is around product development, distribution, testing and validation.But the size of the partner and your preparation can make or break your growth strategy.

 

Join JLABS, Allen & Overy and O’Melveny to learn more and discuss key questions such as:

 

  • Why collaborate?
  • What are the key considerations when starting a collaboration?
  • What are the basics of joint ventures?
  • What are the IP considerations?
  • How do you prepare for potential outcomes and exists?
  • What is the impact of insolvency or bankruptcy of one of the parties on the licensing agreement?

 

We will also look at issues such as force majeure, and provide some 'real life examples' seen during the COVID-19 crisis.

 

This program is part of the Johnson & Johnson Innovation – JLABS Legal Webinar Series for life science entrepreneurs, together with Allen & Overy and O’Melveny. You can register for other webinars in the series by visiting this page.

Text Block #1

Entering a strategic collaboration as a startup can be enormously beneficial to get your innovation to the next level, whether it is around product development, distribution, testing and validation.But the size of the partner and your preparation can make or break your growth strategy.

 

Join JLABS, Allen & Overy and O’Melveny to learn more and discuss key questions such as:

 

  • Why collaborate?
  • What are the key considerations when starting a collaboration?
  • What are the basics of joint ventures?
  • What are the IP considerations?
  • How do you prepare for potential outcomes and exists?
  • What is the impact of insolvency or bankruptcy of one of the parties on the licensing agreement?

 

We will also look at issues such as force majeure, and provide some 'real life examples' seen during the COVID-19 crisis.

 

This program is part of the Johnson & Johnson Innovation – JLABS Legal Webinar Series for life science entrepreneurs, together with Allen & Overy and O’Melveny. You can register for other webinars in the series by visiting this page.

JLABS on Twitter

Ticket Sales Are Closed
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, ticket sales have closed.